Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Talaris Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/17/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/06/2021 |
3
| Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Agarwala Sandip (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Srivastava Sapna (Director) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Clarus Defined Exit I, L.P. (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| MCDADE MARK (Director) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| GALAKATOS NICHOLAS (Director) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Longitude Capital Partners III, LLC (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Requadt Scott (See Remarks) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| MACKAY GEOFFREY (Director) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Krieger Nancy (Chief Medical Officer) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Shah Gaurav (Director) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Zdanowski Michael (Chief Technology Officer) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Nader Francois (Director) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Ildstad Suzanne (Chief Scientific Officer) has filed a Form 3 on Talaris Therapeutics, Inc. |
05/06/2021 |
3
| Fenton Mary Kay (CFO) has filed a Form 3 on Talaris Therapeutics, Inc. |
|
|